Franklin Resources
TRVI icon

Franklin Resources’s Trevi Therapeutics TRVI Stock Holding History

Franklin Resources’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$595K Hold
49,878
– – ﹤0.01% 2403
2025
Q4 		$624K Hold
49,878
– – ﹤0.01% 2302
2025
Q3 		$456K Sell
49,878
-40
-0.1% -$300 ﹤0.01% 2468
2025
Q2 		$273K Buy
49,918
+12,647
+34% +$78.7K ﹤0.01% 2600
2025
Q1 		$234K Buy
+37,271
New +$178K ﹤0.01% 2606
2020
Q2 		– Sell
-587,347
Closed -$1.93M – 1738
2020
Q1 		$1.93M Hold
587,347
– – ﹤0.01% 1098
2019
Q4 		$2.2M Sell
587,347
-112,653
-16% -$422K ﹤0.01% 1155
2019
Q3 		$3.15M Hold
700,000
– – ﹤0.01% 1086
2019
Q2 		$5.25M Buy
+700,000
New +$6.03M ﹤0.01% 1015

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return